Skip to Main content Skip to Navigation
Journal articles

Estimating optimal dose of twice-weekly gemcitabine for concurrent chemoradiotherapy in unresectable pancreatic carcinoma: mature results of GEMRT-01 phase I trial

Nicolas Girard F. Mornex Nadine Bossard 1 M. Ychou B. Chauffert V. Wautot
1 Biostatistiques santé
Département biostatistiques et modélisation pour la santé et l'environnement [LBBE]
Document type :
Journal articles
Complete list of metadata

https://hal.archives-ouvertes.fr/hal-00698359
Contributor : Stéphane Delmotte <>
Submitted on : Wednesday, May 16, 2012 - 2:34:27 PM
Last modification on : Tuesday, July 20, 2021 - 5:20:06 PM

Identifiers

  • HAL Id : hal-00698359, version 1

Collections

Citation

Nicolas Girard, F. Mornex, Nadine Bossard, M. Ychou, B. Chauffert, et al.. Estimating optimal dose of twice-weekly gemcitabine for concurrent chemoradiotherapy in unresectable pancreatic carcinoma: mature results of GEMRT-01 phase I trial. International Journal of Radiation Oncology - Biology - Physics, Elsevier, 2010, 77(5), pp.1426-1432. ⟨hal-00698359⟩

Share